Reality of Single Circulating Tumor Cell Sequencing for Molecular Diagnostics in Pancreatic Cancer

Journal of Molecular Diagnostics

Volumn 18, Issue 5, 2016, Pages 688-696

  Court, Colin M ^a,c   Ankeny, Jacob S ^a,c   Sho, Shonan ^a,c   Hou, Shuang ^a,b   Li, Qingyu ^a   Hsieh, Carolyn ^a   Song, Min ^b   Liao, Xinfang ^b   Rochefort, Matthew M ^a,c   Wainberg, Zev A ^a   Graeber, Thomas G ^a,b   Tseng, Hsian Rong ^b   Tomlinson, James S ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

K RAS PROTEIN; KRAS PROTEIN, HUMAN; PROTEIN P21; TUMOR MARKER;

ALLELE; ARTICLE; CANCER DIAGNOSIS; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; FEASIBILITY STUDY; GENE AMPLIFICATION; GENE SEQUENCE; GENOME ANALYSIS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; LASER CAPTURE MICRODISSECTION; LEUKOCYTE; MOLECULAR DIAGNOSIS; MUTATIONAL ANALYSIS; PANCREAS CANCER; SINGLE CELL ANALYSIS; DNA MUTATIONAL ANALYSIS; DNA SEQUENCE; GENETICS; GENOTYPE; METABOLISM; MICROCHIP ANALYSIS; PANCREATIC NEOPLASMS; PATHOLOGY; POLYMERASE CHAIN REACTION; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TUMOR CELL LINE; TUMOR EMBOLISM;

BIOMARKERS, TUMOR; CELL LINE, TUMOR; DNA MUTATIONAL ANALYSIS; GENOTYPE; HUMANS; MICROCHIP ANALYTICAL PROCEDURES; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASTIC CELLS, CIRCULATING; PANCREATIC NEOPLASMS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS P21(RAS); REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; SINGLE-CELL ANALYSIS;

EID: 84991263750     PISSN: 15251578     EISSN: 19437811     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2016.03.006     Document Type: Article

References (31)

1. 1 Mendelsohn, J., Personalizing oncology: perspectives and prospects. J Clin Oncol 31 (2013), 1904–1911.
2. 2 LeBlanc, J.K., Ciaccia, D., Al-Assi, M.T., McGrath, K., Imperiale, T., Tao, L.C., Vallery, S., DeWitt, J., Sherman, S., Collins, E., Optimal number of EUS-guided fine needle passes needed to obtain a correct diagnosis. Gastrointest Endosc 59 (2004), 475–481.
3. 3 Alix-Panabieres, C., Pantel, K., Challenges in circulating tumour cell research. Nat Rev Cancer 14 (2014), 623–631.
4. 4 Gold, B., Cankovic, M., Furtado, L.V., Meier, F., Gocke, C.D., Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology. J Mol Diagn 17 (2015), 209–224.
5. 5 Allard, W.J., Matera, J., Miller, M.C., Repollet, M., Connelly, M.C., Rao, C., Tibbe, A.G., Uhr, J.W., Terstappen, L.W., Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10 (2004), 6897–6904.
6. 6 Court, C.M., Ankeny, J.S., Hou, S., Tseng, H.R., Tomlinson, J.S., Improving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysis. Expert Rev Mol Diagn 15 (2015), 1491–1504.
7. 7 Navin, N.E., The first five years of single-cell cancer genomics and beyond. Genome Res 25 (2015), 1499–1507.
8. 8 de Bourcy, C.F., De Vlaminck, I., Kanbar, J.N., Wang, J., Gawad, C., Quake, S.R., A quantitative comparison of single-cell whole genome amplification methods. PLoS One, 9, 2014, e105585.
9. 9 Gawad, C., Koh, W., Quake, S.R., Single-cell genome sequencing: current state of the science. Nat Rev Genet 17 (2016), 175–188.
10. 10 Almoguera, C., Shibata, D., Forrester, K., Martin, J., Arnheim, N., Perucho, M., Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53 (1988), 549–554.
11. 11 Bryant, K.L., Mancias, J.D., Kimmelman, A.C., Der, C.J., KRAS: feeding pancreatic cancer proliferation. Trends Biochem Sci 39 (2014), 91–100.
12. 12 Girgis, M.D., Olafsen, T., Kenanova, V., McCabe, K.E., Wu, A.M., Tomlinson, J.S., Targeting CEA in pancreas cancer xenografts with a mutated scFv-Fc antibody fragment. EJNMMI Res, 1, 2011, 24.
13. 13 Lin, M., Chen, J.F., Lu, Y.T., Zhang, Y., Song, J., Hou, S., Ke, Z., Tseng, H.R., Nanostructure embedded microchips for detection, isolation, and characterization of circulating tumor cells. Acc Chem Res 47 (2014), 2941–2950.
14. 14 Zhao, L., Lu, Y.T., Li, F., Wu, K., Hou, S., Yu, J., Shen, Q., Wu, D., Song, M., OuYang, W.H., Luo, Z., Lee, T., Fang, X., Shao, C., Xu, X., Garcia, M.A., Chung, L.W., Rettig, M., Tseng, H.R., Posadas, E.M., High-purity prostate circulating tumor cell isolation by a polymer nanofiber-embedded microchip for whole exome sequencing. Adv Mater 25 (2013), 2897–2902.
15. 15 Ankeny, J.S., Court, C.M., Hou, S., Li, Q., Song, M., Wu, D., Chen, J.F., Lee, T., Lin, M., Sho, S., Rochefort, M.M., Girgis, M.D., Yao, J., Wainberg, Z.A., Muthusamy, V.R., Watson, R.R., Donahue, T.R., Hines, O.J., Reber, H.A., Graeber, T.G., Tseng, H.R., Tomlinson, J.S., Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer. Br J Cancer 114 (2016), 1367–1375.
16. 16 Huggett, J.F., Foy, C.A., Benes, V., Emslie, K., Garson, J.A., Haynes, R., Hellemans, J., Kubista, M., Mueller, R.D., Nolan, T., Pfaffl, M.W., Shipley, G.L., Vandesompele, J., Wittwer, C.T., Bustin, S.A., The digital MIQE guidelines: minimum Information for Publication of Quantitative Digital PCR Experiments. Clin Chem 59 (2013), 892–902.
17. 17 Hamidi, H., Lu, M., Chau, K., Anderson, L., Fejzo, M., Ginther, C., Linnartz, R., Zubel, A., Slamon, D.J., Finn, R.S., KRAS mutational subtype and copy number predict in vitro response of human pancreatic cancer cell lines to MEK inhibition. Br J Cancer 111 (2014), 1788–1801.
18. 18 Rehm, H.L., Bale, S.J., Bayrak-Toydemir, P., Berg, J.S., Brown, K.K., Deignan, J.L., Friez, M.J., Funke, B.H., Hegde, M.R., Lyon, E., Working Group of the American College of Medical Genetics and Genomics Laboratory Quality Assurance Committee. ACMG clinical laboratory standards for next-generation sequencing. Genet Med 15 (2013), 733–747.
19. 19 Ballantyne, K.N., van Oorschot, R.A., Muharam, I., van Daal, A., John Mitchell, R., Decreasing amplification bias associated with multiple displacement amplification and short tandem repeat genotyping. Anal Biochem 368 (2007), 222–229.
20. 20 Van Loo, P., Voet, T., Single cell analysis of cancer genomes. Curr Opin Genet Dev 24 (2014), 82–91.
21. 21 Tsiatis, A.C., Norris-Kirby, A., Rich, R.G., Hafez, M.J., Gocke, C.D., Eshleman, J.R., Murphy, K.M., Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications. J Mol Diagn 12 (2010), 425–432.
22. 22 Soh, J., Okumura, N., Lockwood, W.W., Yamamoto, H., Shigematsu, H., Zhang, W., Chari, R., Shames, D.S., Tang, X., MacAulay, C., Varella-Garcia, M., Vooder, T., Wistuba, I.I., Lam, S., Brekken, R., Toyooka, S., Minna, J.D., Lam, W.L., Gazdar, A.F., Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells. PLoS One, 4, 2009, e7464.
23. 23 Aoki, Y., Hosaka, S., Tachibana, N., Karasawa, Y., Kawa, S., Kiyosawa, K., Reassessment of K-ras mutations at codon 12 by direct PCR and sequencing from tissue microdissection in human pancreatic adenocarcinomas. Pancreas 21 (2000), 152–157.
24. 24 Zong, C., Lu, S., Chapman, A.R., Xie, X.S., Genome-wide detection of single-nucleotide and copy-number variations of a single human cell. Science 338 (2012), 1622–1626.
25. 25 Ni, X., Zhuo, M., Su, Z., Duan, J., Gao, Y., Wang, Z., Zong, C., Bai, H., Chapman, A.R., Zhao, J., Xu, L., An, T., Ma, Q., Wang, Y., Wu, M., Sun, Y., Wang, S., Li, Z., Yang, X., Yong, J., Su, X.D., Lu, Y., Bai, F., Xie, X.S., Wang, J., Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients. Proc Natl Acad Sci U S A 110 (2013), 21083–21088.
26. 26 Yu, Z., Lu, S., Huang, Y., Microfluidic whole genome amplification device for single cell sequencing. Anal Chem 86 (2014), 9386–9390.
27. 27 Chinen, L.T., de Carvalho, F.M., Rocha, B.M., Aguiar, C.M., Abdallah, E.A., Campanha, D., Mingues, N.B., de Oliveira, T.B., Maciel, M.S., Cervantes, G.M., Dettino, A.L., Soares, F.A., Paterlini-Brechot, P., Fanelli, M.F., Cytokeratin-based CTC counting unrelated to clinical follow up. J Thorac Dis 5 (2013), 593–599.
28. 28 Lustberg, M.B., Balasubramanian, P., Miller, B., Garcia-Villa, A., Deighan, C., Wu, Y., Carothers, S., Berger, M., Ramaswamy, B., Macrae, E.R., Wesolowski, R., Layman, R.M., Mrozek, E., Pan, X., Summers, T.A., Shapiro, C.L., Chalmers, J.J., Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients. Breast Cancer Res, 16, 2014, R23.
29. 29 Heitzer, E., Auer, M., Gasch, C., Pichler, M., Ulz, P., Hoffmann, E.M., Lax, S., Waldispuehl-Geigl, J., Mauermann, O., Lackner, C., Hofler, G., Eisner, F., Sill, H., Samonigg, H., Pantel, K., Riethdorf, S., Bauernhofer, T., Geigl, J.B., Speicher, M.R., Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing. Cancer Res 73 (2013), 2965–2975.
30. 30 Lohr, J.G., Adalsteinsson, V.A., Cibulskis, K., Choudhury, A.D., Rosenberg, M., Cruz-Gordillo, P., et al. Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer. Nat Biotechnol 32 (2014), 479–484.
31. 31 Hou, Y., Song, L., Zhu, P., Zhang, B., Tao, Y., Xu, X., et al. Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm. Cell 148 (2012), 873–885.